The MIRI was very well represented at the annual Perinatal Research Society Annual Meeting Utah from September 29-October 1, in the beautiful setting of Park City.
A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.
Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.
A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.